SOX7 and neoplasm: It should be emphasized that SOX7 re-expression rescued both the SHP2-inefficiency-induced endothelial dysfunction in vitro and SHP2-deletion-induced impairment of tumor angiogenesis in vivo, demonstrating the unique and critical role of this proangiogenic factor in mediating the regulation of tumor angiogenesis by SHP2.